Journal
CLINICAL EPIGENETICS
Volume 13, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13148-021-01089-3
Keywords
Inflammatory bowel disease; Crohn's disease; Epigenetic modifications; DNA methylation; Epigenetic technologies; Biostatistics
Categories
Funding
- Projekt DEAL
- EU Social Fund [ESF/14-BM-A55-0027/18]
- Federal German Ministry for Education and Research [FK 01ZX1709, FK 01ZX1905B]
Ask authors/readers for more resources
Epigenetics plays a crucial role in inflammatory bowel diseases, particularly in Crohn's disease, which is believed to be a result of a complex interplay between genetic susceptibility, environmental factors, and altered intestinal microbiota. While many genetic variants have been associated with Crohn's disease, the influence of epigenetics in its pathogenesis remains relatively unknown.
Epigenetics has become a promising field for finding new biomarkers and improving diagnosis, prognosis, and drug response in inflammatory bowel disease. The number of people suffering from inflammatory bowel diseases, especially Crohn's disease, has increased remarkably. Crohn's disease is assumed to be the result of a complex interplay between genetic susceptibility, environmental factors, and altered intestinal microbiota, leading to dysregulation of the innate and adaptive immune response. While many genetic variants have been identified to be associated with Crohn's disease, less is known about the influence of epigenetics in the pathogenesis of this disease. In this review, we provide an overview of current epigenetic studies in Crohn's disease. In particular, we enable a deeper insight into applied bioanalytical and computational tools, as well as a comprehensive update toward the cell-specific evaluation of DNA methylation and histone modifications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available